Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Diastolic Dysfunction in Type 2 Diabetes
NCT02655770Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Feb 2016
- Primary completion
- Dec 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in diastolic dysfunction, sponsored by Rigshospitalet. Started Feb 2016; status: completed.
02
Drugs
03
Conditions
diastolic dysfunction
Beyond the preview
Go deeper on NCT02655770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655770.